Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 212.70
-5.20 (-2.39%)
At close: Aug 17, 2026
Hikal Revenue
Hikal had revenue of 4.03B INR in the quarter ending June 30, 2026, with 5.89% growth. This brings the company's revenue in the last twelve months to 17.35B, down -5.37% year-over-year. In the fiscal year ending March 31, 2026, Hikal had annual revenue of 17.13B, down -7.91%.
Revenue (ttm)
17.35B
Revenue Growth
-5.37%
P/S Ratio
1.55
Revenue / Employee
8.41M
Employees
2,062
Market Cap
26.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 17.13B | -1.47B | -7.91% |
| Mar 31, 2025 | 18.60B | 752.00M | 4.21% |
| Mar 31, 2024 | 17.85B | -2.38B | -11.79% |
| Mar 31, 2023 | 20.23B | 803.09M | 4.13% |
| Mar 31, 2022 | 19.43B | 2.22B | 12.92% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 23.17B |
| Morepen Laboratories | 19.51B |
| Gufic Biosciences | 9.81B |
| TTK Healthcare | 8.88B |
| Venus Remedies | 8.11B |
| Fredun Pharmaceuticals | 7.44B |
| Kwality Pharmaceuticals | 5.54B |
| Amrutanjan Health Care | 5.11B |
Hikal News
- 2 months ago - Hikal shares fall over 7% as Q4 net profit drops 71% YoY to Rs 14.4 crore, EBITDA down 14.6% - Business Upturn
- 2 months ago - Hikal reports Q4 FY26 revenue of Rs 519 crore with 20.3% EBITDA margin - Business Upturn
- 2 months ago - Hikal Q4 Results: Net profit falls 71% YoY to Rs 14.4 crore, revenue down 6% - Business Upturn
- 4 months ago - Pharma sector stocks surge sharply today, April 8: Sudeep Pharma rally 9.41%, KIMS up 5.52%, HIKAL jumps 5.30% - Business Upturn
- 6 months ago - Pharma sector stocsk today, Feb 12: Hikal jumps 13.46%, Zydus up 2.44%, Biocon rises 2.31% - Business Upturn
- 6 months ago - Hikal shares rally sharply over 10% on solid Q3 results - Business Upturn
- 9 months ago - Hikal shares rally over 12% today; Details here - Business Upturn
- 9 months ago - Hikal shares fall over 5% as company reports Q2 net loss and nearly 30% drop in sales - Business Upturn